Stock Scorecard
Stock Summary for Syndax Pharmaceuticals Inc (SNDX) - $16.33 as of 8/29/2025 9:11:15 PM EST
Total Score
4 out of 30
Safety Score
35 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for SNDX
Positive Quarterly and Annual earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the Annual earnings growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for SNDX
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for SNDX
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 | |
Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for SNDX
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Safety Rating Criteria for SNDX (35 out of 100)
Stock Price Rating (Max of 10) | 6 |
Historical Stock Price Rating (Max of 10) | 7 |
Stock Price Trend (Max of 10) | 2 |
Book Value (Max of 10) | 2 |
Book Value to Price (Max of 10) | 0 |
Analyst Buy Ratings (Max of 5) | 5 |
Analyst Strong Buy Ratings (Max of 5) | 4 |
Dividend Yield Percentage (Max of 10) | 0 |
Operating Margin (Max of 10) | 0 |
Trading Volume (Max of 10) | 9 |
Price to Earnings (Max of 10) | 0 |
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for SNDX
Financial Details for SNDX
Company Overview |
|
---|---|
Ticker | SNDX |
Company Name | Syndax Pharmaceuticals Inc |
Country | USA |
Description | Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. The company is headquartered in Waltham, Massachusetts. |
Sector Name | LIFE SCIENCES |
Industry Name | PHARMACEUTICAL PREPARATIONS |
Most Recent Quarter | 6/30/2025 |
Next Earnings Date | 11/11/2025 |
Stock Price History |
|
Last Day Price | 16.33 |
Price 4 Years Ago | 21.89 |
Last Day Price Updated | 8/29/2025 9:11:15 PM EST |
Last Day Volume | 1,608,464 |
Average Daily Volume | 2,644,337 |
52-Week High | 22.50 |
52-Week Low | 8.58 |
Last Price to 52 Week Low | 90.33% |
Valuation Measures |
|
Trailing PE | N/A |
Industry PE | 40.47 |
Sector PE | 60.89 |
5-Year Average PE | 4.90 |
Free Cash Flow Ratio | 12.96 |
Industry Free Cash Flow Ratio | 15.46 |
Sector Free Cash Flow Ratio | 30.76 |
Current Ratio Most Recent Quarter | 4.71 |
Total Cash Per Share | 1.26 |
Book Value Per Share Most Recent Quarter | 1.83 |
Price to Book Ratio | 8.90 |
Industry Price to Book Ratio | 28.68 |
Sector Price to Book Ratio | 26.74 |
Price to Sales Ratio Twelve Trailing Months | 17.97 |
Industry Price to Sales Ratio Twelve Trailing Months | 25.19 |
Sector Price to Sales Ratio Twelve Trailing Months | 13.32 |
Analyst Buy Ratings | 10 |
Analyst Strong Buy Ratings | 2 |
Share Statistics |
|
Total Shares Outstanding | 86,142,000 |
Market Capitalization | 1,406,698,860 |
Institutional Ownership | 121.44% |
Dividends |
|
Ex-Dividend Date | N/A |
Previous Dividend Amount | 0.0000 |
Current Dividend Amount | 0.0000 |
Total Years Dividend Increasing | N/A |
Trailing Annual Dividend Rate | 0.00 |
Trailing Annual Dividend Yield | 0.00% |
Forward Annual Dividend Rate | 0.00 |
Forward Annual Dividend Yield | 0.00% |
5-Year Dividend Payments Count | 0 |
3-Year Average Dividend Yield | 0.00% |
5-Year Average Dividend Yield | 0.00% |
1-Year Dividend Growth Rate Percentage | 0.00% |
3-Year Dividend Growth Rate Percentage | 0.00% |
5-Year Dividend Growth Rate Percentage | 0.00% |
All-Time Dividend Growth Rate Percentage | 0.00% |
Dividend Payout Ratio | N/A |
Income Statement |
|
Quarterly Earnings Growth YOY | 0.00% |
Annual Earnings Growth | -52.25% |
Reported EPS 12 Trailing Months | -3.89 |
Reported EPS Past Year | -1.81 |
Reported EPS Prior Year | -3.73 |
Net Income Twelve Trailing Months | -334,988,000 |
Net Income Past Year | -318,758,000 |
Net Income Prior Year | -209,360,000 |
Quarterly Revenue Growth YOY | 985.00% |
5-Year Revenue Growth | 73.25% |
Operating Margin Twelve Trailing Months | -182.70% |
Balance Sheet |
|
Total Cash Most Recent Quarter | 108,636,000 |
Total Cash Past Year | 154,083,000 |
Total Cash Prior Year | 295,394,000 |
Net Cash Position Most Recent Quarter | -222,929,000 |
Net Cash Position Past Year | -177,482,000 |
Long Term Debt Past Year | 331,565,000 |
Long Term Debt Prior Year | 59,894,664 |
Total Debt Most Recent Quarter | 331,565,000 |
Equity to Debt Ratio Past Year | 0.46 |
Equity to Debt Ratio Most Recent Quarter | 0.32 |
Total Stockholder Equity Past Year | 288,124,000 |
Total Stockholder Equity Prior Year | 554,196,000 |
Total Stockholder Equity Most Recent Quarter | 157,424,000 |
Free Cash Flow |
|
Free Cash Flow Twelve Trailing Months | -302,667,000 |
Free Cash Flow Per Share Twelve Trailing Months | -3.51 |
Free Cash Flow Past Year | -274,903,000 |
Free Cash Flow Prior Year | -160,601,000 |
Options |
|
Put/Call Ratio | 0.34 |
Has Options | Options Chain |
Liquidity Rating | |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | 1.49 |
MACD Signal | 1.37 |
20-Day Bollinger Lower Band | 6.59 |
20-Day Bollinger Middle Band | 11.37 |
20-Day Bollinger Upper Band | 16.16 |
Beta | 0.73 |
RSI | 74.77 |
50-Day SMA | 13.97 |
150-Day SMA | 18.60 |
200-Day SMA | 18.63 |
System |
|
Modified | 8/28/2025 10:37:49 AM EST |